Showing results (281-290 of 302) with videos related to
Sort By:
Pageof 31
American Journal of Hematology|January 12, 2017
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agentsElias Jabbour, Paolo Strati, Monica Cabrero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumMichael D Jain, Jay Y Spiegel, Loretta J Nastoupil, et al.Cancer Cell|June 13, 2023
Single cell clonotypic and transcriptional evolution of multiple myeloma precursor diseaseMinghao Dang, Ruiping Wang, Hans C Lee, et al.JAMA Network Open|September 29, 2020
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation TherapyChelsea C Pinnix, Jillian R Gunther, Penny Fang, et al.Cancer|November 21, 2014
Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research ConsortiumElias J Jabbour, Guillermo Garcia-Manero, Paolo Strati, et al.Science Translational Medicine|June 21, 2019
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphomaNeeraj Jain, Keenan Hartert, Saber Tadros, et al.Advances in Radiation Oncology|November 18, 2024
Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?Penny Fang, Sonal S Noticewala, Susan Y Wu, et al.The Lancet. Oncology|December 7, 2018
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trialFrederick L Locke, Armin Ghobadi, Caron A Jacobson, et al.Nature Reviews. Clinical Oncology|August 8, 2018
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKris M Mahadeo, Sajad J Khazal, Hisham Abdel-Azim, et al.Transplantation and Cellular Therapy|March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like SyndromeMelissa R Hines, Tristan E Knight, Kevin O McNerney, et al.Pageof 31